Sanofi SA (SNY)
46.32
+0.91
(+2.00%)
USD |
NASDAQ |
Apr 19, 16:00
46.29
-0.03
(-0.06%)
After-Hours: 20:00
Sanofi Shareholders Equity (Quarterly): 81.84B for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 81.84B |
| June 30, 2023 | 78.93B |
| December 31, 2022 | 80.20B |
| June 30, 2022 | 74.11B |
| December 31, 2021 | 77.76B |
| June 30, 2021 | 75.25B |
| June 30, 2020 | 71.20B |
| December 31, 2019 | 66.15B |
| June 30, 2019 | 64.07B |
| December 31, 2018 | 67.35B |
| June 30, 2018 | 64.98B |
| December 31, 2017 | 69.67B |
| December 31, 2016 | 60.84B |
| December 31, 2015 | 63.46B |
| June 30, 2015 | 63.50B |
| December 31, 2014 | 68.24B |
| June 30, 2014 | 70.45B |
| December 31, 2013 | 78.58B |
| June 30, 2013 | 73.07B |
| December 31, 2012 | 75.85B |
| June 30, 2012 | 69.93B |
| Date | Value |
|---|---|
| December 31, 2011 | 72.79B |
| June 30, 2011 | 75.94B |
| December 31, 2010 | 70.62B |
| June 30, 2010 | 64.10B |
| December 31, 2009 | 69.10B |
| June 30, 2009 | 62.63B |
| December 31, 2008 | 62.70B |
| June 30, 2008 | 65.17B |
| December 31, 2007 | 65.01B |
| June 30, 2007 | 62.28B |
| December 31, 2006 | 60.16B |
| June 30, 2006 | 57.60B |
| December 31, 2005 | 54.57B |
| June 30, 2005 | 53.29B |
| December 31, 2004 | 55.65B |
| June 30, 2004 | 8.315B |
| December 31, 2003 | 7.944B |
| June 30, 2003 | 6.429B |
| December 31, 2002 | 6.337B |
| June 30, 2002 | 5.853B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
64.07B
Minimum
Jun 2019
81.84B
Maximum
Dec 2023
74.39B
Average
75.25B
Median
Jun 2021
Shareholders Equity (Quarterly) Benchmarks
| AstraZeneca PLC | 39.14B |
| GSK PLC | 17.00B |
| Novo Nordisk A/S | 15.82B |
| Regeneron Pharmaceuticals Inc | 25.97B |
| Inhibrx Inc | 43.50M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 139.79B |
| Total Liabilities (Quarterly) | 57.60B |
| Debt to Equity Ratio | 0.2214 |
| Current Ratio | 1.267 |
| Net Debt Paydown Yield | -2.91% |